Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ORKA stock hub

Oruka Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ORKAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.9B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ORKA

In the news

Latest news · ORKA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.6P50 18.3P75 33.7

Trailing P/En/a

P25 15P50 23.3P75 38.5

ROE-24.7

P25 -106.6P50 -46.9P75 -3.1

ROIC-17.8

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ORKA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

171

Groups with data

Currency

USD

Showing 171 of 171 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000907654
Company name	Oruka Therapeutics, Inc.
Country	United States
Country code	US
Cusip	687604108
Employees	68
Employees Change	40%
Employees Change Percent	142.9
Enterprise value	$3.4B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US6876041087
Last refreshed	2026-05-10
Market cap	$3.9B
Market cap category	Mid-Cap
Price	$64.59
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	ORKA
Website	https://orukatx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.18%
FCF yield	-2.29%
P/B ratio	6.71x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-84.3M
Net Income Growth Years	0%
Profit Per Employee	$-1.2M
ROA	-17.25
ROCE	-25.79
ROE	-24.69
ROIC	-17.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	577.93%
EPS Growth Years	17
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$488.6M
Cash	$337M
Current Assets	$343.9M
Current Liabilities	$15.4M
Debt	$1.9M
Debt Equity	$0
Equity	$471.9M
Liabilities	$16.7M
Long Term Assets	$144.8M
Long Term Liabilities	$1.3M
Net Cash	$477.7M
Net Cash By Market Cap	$12.35
Net Cash Growth	21.62%
Net Debt Equity	$-1.01
Tangible Book Value	$469M
Tangible Book Value Per Share	$9.63

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	22.37
Net Working Capital	$-7.9M
Quick ratio	21.92
Working Capital	$328.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-171.69%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	577.04%
200-day SMA	31.97
50-day SMA	53.01
50-day SMA vs 200-day SMA	50over200
All Time High	91
All Time High Change	-29.02%
All Time High Date	2026-04-27
All Time Low	5.49
All Time Low Change	1,077.58%
All Time Low Date	2025-04-09
ATR	5.07
Beta1y	0.32
Beta2y	1.19
Ch YTD	113.1
High	65.45
High52	91
High52 Date	2026-04-27
High52ch	-29.02%
Low	63.68
Low52	8.91
Low52 Date	2025-05-15
Low52ch	624.92%
Ma50ch	21.84%
Premarket Change Percent	1.45
Premarket Price	$65
Premarket Volume	1,006
Price vs 200-day SMA	102.06%
RSI	52.26
RSI Monthly	76.49
RSI Weekly	77.15
Sharpe ratio	2.87x
Sortino ratio	5.58
Total Return	-171.69%
Tr YTD	113.1
Tr1m	6.58%
Tr1w	3.21%
Tr3m	95.43%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	12
Analyst Count Top	10
Analyst Price Target Top	$102
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.53
Operating Income	$-122.1M
Price target	$92.5
Price Target Change	$43.21
Price Target Change Top	$57.76

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	50,546,199%
Float Percent	84.45%
Shares Insiders	2.43%
Shares Institutions	75.91%
Shares Out	59,856,914
Shares Qo Q	23.49%
Shares Yo Y	171.69%
Short Float	10.96%
Short Ratio	4.89
Short Shares	9.25

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-112.7M
Average Volume	2,395,237.65x
Bv Per Share	9.63
CAPEX	$-209,000
Ch1m	6.58
Ch1w	3.21
Ch1y	577
Ch3m	95.43
Ch6m	132.8
Change	0.81%
Change From Open	0.62
Close	64.07
Days Gap	0.19
Depreciation Amortization	83,000
Dollar Volume	60,886,667.8
Earnings Date	2026-05-13
Earnings Time	amc
EBIT	$-122.1M
EBITDA	$-122M
EPS	$-1.85
F Score	0
FCF	$-88.4M
FCF EV Yield	-2.61x
FCF Per Share	$-1.48
Financing CF	170,315,000
Fiscal Year End	December
Founded	2,004
Investing CF	-96,745,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-12
Last Report Date	2025-12-31
Last Split Date	2024-09-03
Last Split Type	Reverse
Last10k Filing Date	2026-03-12
Ma150	37.53
Ma150ch	72.12%
Ma20	67.88
Ma20ch	-4.85%
Net CF	-14,640,000
Next Earnings Date	2026-05-22
Open	64.19
Optionable	Yes
Position In Range	51.41
Post Close	64.59
Postmarket Change Percent	1.83
Postmarket Price	$65.77
Ppne	2,118,000
Pre Close	64.07
Price Date	2026-05-08
Ptbv Ratio	8.24
Relative Volume	0.39x
Share Based Comp	24,240,000
Tr6m	132.76%
Us State	California
Volume	942,664

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ORKA pay a dividend?

Capital-return profile for this ticker.

Performance

ORKA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ORKA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+75.9%

Float: +84.4% of shares outstanding

Insider ownership

+2.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ORKA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.3

Neutral momentum band

Price vs 200-day MA

+102.1%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

2.87

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ORKA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ORKA stock rating?

Oruka Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ORKA analysis?

The full report lives at /stocks/ORKA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ORKA?

The latest report frames ORKA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ORKA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.